{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:21Z","timestamp":1753890981915,"version":"3.41.2"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-89833"],"award-info":[{"award-number":["MOP-89833"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01885","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T04:19:00Z","timestamp":1515039540000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference"],"prefix":"10.3389","volume":"8","author":[{"given":"Karine","family":"Chartrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-\u00c8ve","family":"Lebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Tarrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Savard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Lamarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2006-05-023770","article-title":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon","volume":"109","author":"Cervantes-Barragan","year":"2007","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1004588","DOI":"10.1371\/journal.ppat.1004588","article-title":"Early virus-host interactions dictate the course of a persistent infection","volume":"11","author":"Sullivan","year":"2015","journal-title":"PLoS Pathog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"B13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/978-3-642-60411-9_15","article-title":"Adverse effects of interferon treatment","volume-title":"Interferons: Biological Activities and Clinical Efficacy","author":"Aul","year":"1997"},{"key":"B14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","article-title":"Side effects of interferon-alpha therapy","volume":"27","author":"Sleijfer","year":"2005","journal-title":"Pharm World Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1073\/pnas.0631696100","article-title":"Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of toll-like receptor 7","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1128\/JVI.78.10.5223-5232.2004","article-title":"Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells","volume":"78","author":"Fonteneau","year":"2004","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1084\/jem.20041961","article-title":"Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs","volume":"202","author":"Yoneyama","year":"2005","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2002-10-3063","article-title":"Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity","volume":"101","author":"Fonteneau","year":"2003","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.4049\/jimmunol.177.11.7510","article-title":"Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ","volume":"177","author":"Lund","year":"2006","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1003728","DOI":"10.1371\/journal.ppat.1003728","article-title":"Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections","volume":"9","author":"Swiecki","year":"2013","journal-title":"PLoS Pathog"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1073\/pnas.1117359109","article-title":"Plasmacytoid dendritic cells control T-cell response to chronic viral infection","volume":"109","author":"Cervantes-Barragan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.virol.2007.01.011","article-title":"Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization","volume":"363","author":"Denis","year":"2007","journal-title":"Virology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2567.2007.02753.x","article-title":"Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus","volume":"124","author":"Acosta-Ramirez","year":"2008","journal-title":"Immunology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/JVI.01811-07","article-title":"Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation","volume":"82","author":"Lacasse","year":"2008","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e21522","DOI":"10.1371\/journal.pone.0021522","article-title":"Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles","volume":"6","author":"Savard","year":"2011","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.nano.2013.02.009","article-title":"Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge","volume":"9","author":"Mathieu","year":"2013","journal-title":"Nanomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","article-title":"Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infection","volume":"192","author":"Lebel","year":"2014","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-3155-12-19","article-title":"PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine","volume":"12","author":"Rioux","year":"2014","journal-title":"J Nanobiotechnology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7245","DOI":"10.1016\/j.vaccine.2015.10.123","article-title":"Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine","volume":"33","author":"Carignan","year":"2015","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12951-016-0200-2","article-title":"Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine","volume":"14","author":"Rioux","year":"2016","journal-title":"J Nanobiotechnology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601271","article-title":"Complement component 3 regulates IFN-alpha production by plasmacytoid dendritic cells following TLR7 activation by a plant virus-like nanoparticle","volume":"199","author":"Lebel","year":"2016","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12951-017-0289-y","article-title":"A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling","volume":"15","author":"Therien","year":"2017","journal-title":"J Nanobiotechnology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1021\/acs.nanolett.5b04877","article-title":"Potentiating cancer immunotherapy using papaya mosaic virus-derived nanoparticles","volume":"16","author":"Lebel","year":"2016","journal-title":"Nano Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J Virol Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20052359","article-title":"Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus","volume":"203","author":"Smit","year":"2006","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.micinf.2009.02.008","article-title":"Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9","volume":"11","author":"Xie","year":"2009","journal-title":"Microbes Infect"},{"key":"B43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00011-012-0493-z","article-title":"Downregulation of TLR7\/9 leads to deficient production of IFN-alpha from plasmacytoid dendritic cells in chronic hepatitis B","volume":"61","author":"Xu","year":"2012","journal-title":"Inflamm Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1128\/JVI.01741-06","article-title":"Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients","volume":"81","author":"Rodrigue-Gervais","year":"2007","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.4049\/jimmunol.178.7.4436","article-title":"TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection","volume":"178","author":"Yonkers","year":"2007","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/v2112443","article-title":"Inhibition of the type I interferon antiviral response during arenavirus infection","volume":"2","author":"Borrow","year":"2010","journal-title":"Viruses"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.1128\/JVI.00155-10","article-title":"Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus","volume":"84","author":"Zhou","year":"2010","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular toll-like receptors","volume":"32","author":"Blasius","year":"2010","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.4049\/jimmunol.166.8.5161","article-title":"Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators","volume":"166","author":"Lehner","year":"2001","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2567.2005.02211.x","article-title":"Differential effects of CpG-DNA in toll-like receptor-2\/-4\/-9 tolerance and cross-tolerance","volume":"116","author":"Dalpke","year":"2005","journal-title":"Immunology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1189\/jlb.2A0515-197R","article-title":"TLR4, TLR7\/8 agonist-induced miR-146a promotes macrophage tolerance to MyD88-dependent TLR agonists","volume":"100","author":"Nahid","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1073\/pnas.0813037106","article-title":"Prevention of autoimmune disease by induction of tolerance to toll-like receptor 7","volume":"106","author":"Hayashi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.4049\/jimmunol.173.4.2736","article-title":"Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1","volume":"173","author":"Siedlar","year":"2004","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1158\/0008-5472.CAN-10-3903","article-title":"Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance","volume":"71","author":"Bourquin","year":"2011","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.4049\/jimmunol.174.11.6657","article-title":"Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q","volume":"174","author":"Omatsu","year":"2005","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1182\/blood-2004-07-2529","article-title":"Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow","volume":"105","author":"Pelayo","year":"2005","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.4049\/jimmunol.1000454","article-title":"Plasmacytoid dendritic cell dichotomy: identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset","volume":"186","author":"Bjorck","year":"2011","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1073\/pnas.1610630114","article-title":"A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/eji.201343498","article-title":"Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response","volume":"43","author":"Niederquell","year":"2013","journal-title":"Eur J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/JVI.78.6.2666-2673.2004","article-title":"Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors","volume":"78","author":"Sumida","year":"2004","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"Chen","year":"1993","journal-title":"Int Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2893.2007.00904.x","article-title":"Defective response to toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection","volume":"15","author":"Villacres","year":"2008","journal-title":"J Viral Hepat"},{"key":"B66","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.160.6.2932","article-title":"Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication","volume":"160","author":"Yeow","year":"1998","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1128\/JVI.78.15.8219-8228.2004","article-title":"Characterization of the murine alpha interferon gene family","volume":"78","author":"van Pesch","year":"2004","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/eji.200838311","article-title":"Anti-retroviral effects of type I IFN subtypes in vivo","volume":"39","author":"Gerlach","year":"2009","journal-title":"Eur J Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2172-9-69","article-title":"Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1","volume":"9","author":"Albrecht","year":"2008","journal-title":"BMC Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4049\/jimmunol.1102181","article-title":"TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7\/9","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.4049\/jimmunol.0903662","article-title":"An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis","volume":"184","author":"Schwab","year":"2010","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/vaccines3030620","article-title":"Plant viruses as nanoparticle-based vaccines and adjuvants","volume":"3","author":"Lebel","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1128\/JVI.01720-06","article-title":"Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells","volume":"81","author":"Leclerc","year":"2007","journal-title":"J Virol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1111\/j.1742-4658.2012.08583.x","article-title":"Mapping the surface-exposed regions of papaya mosaic virus nanoparticles","volume":"279","author":"Rioux","year":"2012","journal-title":"FEBS J"},{"key":"B76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-3155-11-10","article-title":"Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP","volume":"11","author":"Babin","year":"2013","journal-title":"J Nanobiotechnology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.4049\/jimmunol.1201477","article-title":"Anti-IFN-alpha\/beta receptor antibody treatment ameliorates disease in lupus-predisposed mice","volume":"189","author":"Baccala","year":"2012","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:54:18Z","timestamp":1693392858000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2017.01885"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01885","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2018,1,4]]},"article-number":"1885"}}